Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00141492 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes
A Phase 2 study, sponsored by Solvay Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00141492: Completed Phase 2 study, sponsored by Solvay Pharmaceuticals.
NCT00141492 is a Phase 2 study that has completed, run by Solvay Pharmaceuticals. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00141492, a Phase 2 study, has completed, sponsored by Solvay Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This study is to investigate how well Androgel, when tested against placebo gel, helps to control blood sugar levels in males with type 2 diabetes who have low testosterone (the main male hormone) blood levels and are taking oral diabetic medicines alone or in combination with insulin.
Interventions
- DRUG Androgel (testosterone gel)
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-10 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
What the finished NCT00141492 record still lists
NCT00141492 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Androgel (testosterone gel) is the first listed.
NCT00141492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00141492 about?
NCT00141492 is a clinical study titled "Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes". This study is to investigate how well Androgel, when tested against placebo gel, helps to control blood sugar levels in males with type 2 diabetes who have low testosterone (the main male hormone) blood levels and are taking oral diabetic medicines alone or in combination with insulin.
What is the current status of trial NCT00141492?
This trial is currently completed. It is a Phase 2 study. The study started on 2004-10. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00141492?
The interventions under investigation include: Androgel (testosterone gel) (DRUG).
Who is sponsoring clinical trial NCT00141492?
This trial is sponsored by Solvay Pharmaceuticals, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia